Show simple item record

dc.contributoren-US
dc.creatorYuniar, Yuyun; Pusat Teknologi Intervensi Kesehatan Masyarakat, Badan Litbangkes, Jl. Percetakan Negara no. 29 Jakarta Pusat 10560
dc.creatorSyarifuddin, Muhammad; Pusat Teknologi Intervensi Kesehatan Masyarakat, Badan Litbangkes, Jl. Percetakan Negara no. 29 Jakarta Pusat 10560
dc.creatorIsakh, Bryan Mario; Pusat Teknologi Intervensi Kesehatan Masyarakat, Badan Litbangkes, Jl. Percetakan Negara no. 29 Jakarta Pusat 10560
dc.date2015-01-07
dc.date.accessioned2019-12-17T02:19:55Z
dc.date.available2019-12-17T02:19:55Z
dc.identifierhttp://ejournal.litbang.depkes.go.id/index.php/hsr/article/view/3586
dc.identifier10.22435/bpsk.v17i2 Apr.3586
dc.identifier.urihttp://r2kn.litbang.kemkes.go.id:8080/handle/123456789/82008
dc.descriptionBackground: The escalation of HIV-AIDS epidemic needs a comprehensive control efforts including the treatmentstage. ARV is inevitably needed to control the development of HIV-AIDS infection. The availability and accessibility of ARVis crucial to reach the successful treatment. Objective: To identify the implementation of logistic management process inthe central level. Methods: Conducting in depth interviews with informants from AIDS and Infectious Disease sub divisionof the Directorate General of Disease Prevention and Control-MoH, Directorate General Pharmacy and Medical Devices,GF-ATM, and PT. Kimia Farma as the manufacturer of ARV in Indonesia. Data was collected in Jakarta during May-August2011. Result: Source of fund procurement of ARV drugs in Indonesia comes from the national budget and Global Fund.Kimia Farma is the only national manufacture of 5-drugs firts line of ARV, while second line ARV is import include rawmaterials of ARVs. Logistics management consists of planning, procurement and storage, and distribution. Conclusion:Logistic management of ARV in the central level has run in accordance to drug logistic cycle. Unfortunately, most rawactive materials and final second line of ARVs product were still being imported. The government has planned an exitstrategy to reduce the dependency on the donor funding. The report and coordination process among the government,PT. Kimia Farma and end user (hospitals) has not worked well and synchronized. Recommendation: The governmenthave to encourage the local pharmaceutical industries to be able to produce ARV, especially the second line. All relatedstakeholders should enhance good coordination through periodic monitoring and evaluation in ARV distribution processand human resources capability in reporting mechanism.en-US
dc.formatapplication/pdf
dc.languageen
dc.publisherPusat Penelitian dan Pengembangan Humaniora dan Manajemen Kesehatanen-US
dc.rightsThe Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Bulletin of Health System Research, and Center of Research and Development for Humaniora and Health Management as publisher of the journal.Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, such as electronic, electrostatic and mechanical copies, photocopies, recordings, magnetic media, etc. , will be allowed only with a written permission from Bulletin of Health System Research, and Center of Research and Development for Humaniora and Health Management.Bulletin of Health System Research, and Center of Research and Development for Humaniora and Health Management, the Editors and the Advisory International Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal.
dc.sourceBuletin Penelitian Sistem Kesehatan; Vol 17, No 2 Apr (2014); 125-134en-US
dc.sourceBuletin Penelitian Sistem Kesehatan; Vol 17, No 2 Apr (2014); 125-134id-ID
dc.subjectHealthen-US
dc.subjectManagement; logistic; Antiretroviralen-US
dc.titleLogistic Management of Antiretrovirals in Indonesiaen-US
dc.typeen-US
dc.typeen-US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record